Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Poniard Pharmaceuticals, Inc. (PARD)

-Other OTC
0.34 Up 0.05(16.92%) Jul 29, 11:21AM EDT
Prev Close:0.29
Open:0.34
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.07
Next Earnings Date:N/A
Day's Range:0.34 - 0.34
52wk Range:0.20 - 0.56
Volume:104
Avg Vol (3m):741
Market Cap:506.51K
P/E (ttm):N/A
EPS (ttm):-3.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PARDUp 16.92%506.51K
BMYUp 2.43%84.57B
IMGNUp 3.99%939.65M
SNYUp 0.43%135.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Mar-11) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback